COPENHAGEN, DENMARK (Feb. 14, 12:30 p.m. ET) — A consortium has been created in Scandinavia by experts in inhaler products who previously worked for AstraZeneca plc.
The pharmaceutical giant has made a series of large-scale cutbacks, including closure of the inhalation technology site in Lund, Sweden.
The Medicon Valley Inhalation Consortium has been formed by people who previously worked at the Lund site, and subsequently started their own new businesses or joined companies offering specialized services within inhalation. The consortium’s president is Orest Lastow, who joined Zenit Design Group after leaving AstraZeneca.
The consortium will work to promote the Skåne-Copenhagen area (a Sweden-Denmark cross-border region) as an international centre of inhalation research and development. Some members of the consortium also worked at inhaler device group Novo Nordisk A/S.
Among the services that the consortium members can offer are: formulation and device development, performance testing, manufacturing of clinical supplies, technology transfer, CMC documentation, NDA filing, product launch and life cycle management.
The consortium’s member companies are: Adroit Science, Validus Engineering, Ligatum, Sturefelt Imaging Resource, Respiron Consulting, CR Competence, EMMACE Consulting and Zenit Design.